HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 08-AUG-19 6Q2T TITLE HUMAN STEROL 14A-DEMETHYLASE (CYP51) IN COMPLEX WITH THE FUNCTIONALLY TITLE 2 IRREVERSIBLE INHIBITOR (R)-N-(1-(3-CHLORO-4'-FLUORO-[1,1'-BIPHENYL]- TITLE 3 4-YL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-(3-FLUORO-5-(5-FLUOROPYRIMIDIN- TITLE 4 4-YL)PHENYL)-1,3,4-OXADIAZOL-2-YL)BENZAMIDE CAVEAT 6Q2T DXC A 603 HAS WRONG CHIRALITY AT ATOM C10 DXC A 604 HAS CAVEAT 2 6Q2T WRONG CHIRALITY AT ATOM C10 DXC A 605 HAS WRONG CHIRALITY CAVEAT 3 6Q2T AT ATOM C10 DXC A 606 HAS WRONG CHIRALITY AT ATOM C10 DXC A CAVEAT 4 6Q2T 607 HAS WRONG CHIRALITY AT ATOM C10 DXC A 608 HAS WRONG CAVEAT 5 6Q2T CHIRALITY AT ATOM C10 DXC A 609 HAS WRONG CHIRALITY AT ATOM CAVEAT 6 6Q2T C10 DXC A 610 HAS WRONG CHIRALITY AT ATOM C10 COMPND MOL_ID: 1; COMPND 2 MOLECULE: LANOSTEROL 14-ALPHA DEMETHYLASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 61-503; COMPND 5 SYNONYM: LDM, CYPLI, CYTOCHROME P450 51A1, CYTOCHROME P450-14DM, COMPND 6 CYTOCHROME P45014DM, CYTOCHROME P450LI, STEROL 14-ALPHA DEMETHYLASE; COMPND 7 EC: 1.14.13.70, 1.14.14.154; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CYP51A1, CYP51; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HMS174; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PCW KEYWDS MONOOXYGENASE, STEROL BIOSYNTHESIS, CYTOCHROME P450, STRUCTURE-BASED KEYWDS 2 DRUG DESIGN, OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR L.FRIGGERI,T.Y.HARGROVE,Z.WAWRZAK,G.I.LEPESHEVA REVDAT 4 11-OCT-23 6Q2T 1 LINK REVDAT 3 01-JAN-20 6Q2T 1 REMARK REVDAT 2 11-DEC-19 6Q2T 1 JRNL REVDAT 1 13-NOV-19 6Q2T 0 JRNL AUTH L.FRIGGERI,T.Y.HARGROVE,Z.WAWRZAK,F.P.GUENGERICH, JRNL AUTH 2 G.I.LEPESHEVA JRNL TITL VALIDATION OF HUMAN STEROL 14 ALPHA-DEMETHYLASE (CYP51) JRNL TITL 2 DRUGGABILITY: STRUCTURE-GUIDED DESIGN, SYNTHESIS, AND JRNL TITL 3 EVALUATION OF STOICHIOMETRIC, FUNCTIONALLY IRREVERSIBLE JRNL TITL 4 INHIBITORS. JRNL REF J.MED.CHEM. V. 62 10391 2019 JRNL REFN ISSN 0022-2623 JRNL PMID 31663733 JRNL DOI 10.1021/ACS.JMEDCHEM.9B01485 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0253 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 26289 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.785 REMARK 3 FREE R VALUE TEST SET COUNT : 1258 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1871 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.95 REMARK 3 BIN R VALUE (WORKING SET) : 0.3740 REMARK 3 BIN FREE R VALUE SET COUNT : 77 REMARK 3 BIN FREE R VALUE : 0.3870 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7172 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 457 REMARK 3 SOLVENT ATOMS : 29 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.58100 REMARK 3 B22 (A**2) : 1.58100 REMARK 3 B33 (A**2) : -3.16200 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.403 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.417 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 23.112 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7871 ; 0.003 ; 0.014 REMARK 3 BOND LENGTHS OTHERS (A): 7284 ; 0.002 ; 0.018 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 10757 ; 1.166 ; 1.741 REMARK 3 BOND ANGLES OTHERS (DEGREES): 16933 ; 1.134 ; 1.676 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 887 ; 6.165 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 390 ;31.611 ;21.744 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1280 ;14.007 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 50 ;13.019 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1023 ; 0.041 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 8483 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1699 ; 0.003 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1933 ; 0.239 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 112 ; 0.351 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3861 ; 0.178 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 200 ; 0.176 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3554 ; 7.348 ;10.068 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 3553 ; 7.342 ;10.067 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4439 ;11.129 ;15.090 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 4440 ;11.129 ;15.092 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 4316 ; 6.923 ;10.414 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 4317 ; 6.922 ;10.413 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 6318 ;10.792 ;15.366 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 6319 ;10.791 ;15.365 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THEIR REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 6Q2T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-AUG-19. REMARK 100 THE DEPOSITION ID IS D_1000243529. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-MAR-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-G REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : DIAMOND(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26405 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 94.350 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 5.600 REMARK 200 R MERGE (I) : 0.04600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.87 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : 0.99600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4UHI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15 MM SODIUM CHOLATE, 8% PEG3350, 0.2 REMARK 280 M POTASSIUM FORMATE, PH 7.4, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 4 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z REMARK 290 4555 Y,-X,Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -Y+1/2,X+1/2,Z+1/2 REMARK 290 8555 Y+1/2,-X+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 58.83200 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 58.83200 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 78.92100 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 58.83200 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 58.83200 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 78.92100 REMARK 290 SMTRY1 7 0.000000 -1.000000 0.000000 58.83200 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 58.83200 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 78.92100 REMARK 290 SMTRY1 8 0.000000 1.000000 0.000000 58.83200 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 58.83200 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 78.92100 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 503 REMARK 465 GLY B 58 REMARK 465 LYS B 503 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 138 -64.91 -103.15 REMARK 500 ALA A 144 -115.54 55.85 REMARK 500 PRO A 148 153.60 -49.20 REMARK 500 ASP A 279 76.51 -100.51 REMARK 500 ARG A 410 24.29 -152.22 REMARK 500 VAL A 440 42.81 -152.99 REMARK 500 ASN A 493 60.12 60.93 REMARK 500 LEU B 71 59.09 -90.15 REMARK 500 ALA B 144 -118.37 61.56 REMARK 500 PRO B 246 66.48 -69.65 REMARK 500 ARG B 410 24.86 -155.38 REMARK 500 VAL B 440 51.44 -155.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 601 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 449 SG REMARK 620 2 HEM A 601 NA 93.8 REMARK 620 3 HEM A 601 NB 80.3 87.8 REMARK 620 4 HEM A 601 NC 84.4 173.6 85.8 REMARK 620 5 HEM A 601 ND 97.9 94.1 177.5 92.3 REMARK 620 6 PJM A 602 NAZ 167.8 95.8 92.6 85.2 88.9 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 601 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 449 SG REMARK 620 2 HEM B 601 NA 97.7 REMARK 620 3 HEM B 601 NB 82.5 87.6 REMARK 620 4 HEM B 601 NC 80.6 173.5 86.0 REMARK 620 5 HEM B 601 ND 95.0 94.3 177.1 92.1 REMARK 620 6 PJM B 602 NAZ 165.2 95.7 91.8 85.4 90.2 REMARK 620 N 1 2 3 4 5 DBREF 6Q2T A 61 503 UNP Q16850 CP51A_HUMAN 61 503 DBREF 6Q2T B 61 503 UNP Q16850 CP51A_HUMAN 61 503 SEQADV 6Q2T GLY A 58 UNP Q16850 EXPRESSION TAG SEQADV 6Q2T LYS A 59 UNP Q16850 EXPRESSION TAG SEQADV 6Q2T LEU A 60 UNP Q16850 EXPRESSION TAG SEQADV 6Q2T GLY B 58 UNP Q16850 EXPRESSION TAG SEQADV 6Q2T LYS B 59 UNP Q16850 EXPRESSION TAG SEQADV 6Q2T LEU B 60 UNP Q16850 EXPRESSION TAG SEQRES 1 A 446 GLY LYS LEU PRO PRO TYR ILE PHE SER PRO ILE PRO PHE SEQRES 2 A 446 LEU GLY HIS ALA ILE ALA PHE GLY LYS SER PRO ILE GLU SEQRES 3 A 446 PHE LEU GLU ASN ALA TYR GLU LYS TYR GLY PRO VAL PHE SEQRES 4 A 446 SER PHE THR MET VAL GLY LYS THR PHE THR TYR LEU LEU SEQRES 5 A 446 GLY SER ASP ALA ALA ALA LEU LEU PHE ASN SER LYS ASN SEQRES 6 A 446 GLU ASP LEU ASN ALA GLU ASP VAL TYR SER ARG LEU THR SEQRES 7 A 446 THR PRO VAL PHE GLY LYS GLY VAL ALA TYR ASP VAL PRO SEQRES 8 A 446 ASN PRO VAL PHE LEU GLU GLN LYS LYS MET LEU LYS SER SEQRES 9 A 446 GLY LEU ASN ILE ALA HIS PHE LYS GLN HIS VAL SER ILE SEQRES 10 A 446 ILE GLU LYS GLU THR LYS GLU TYR PHE GLU SER TRP GLY SEQRES 11 A 446 GLU SER GLY GLU LYS ASN VAL PHE GLU ALA LEU SER GLU SEQRES 12 A 446 LEU ILE ILE LEU THR ALA SER HIS CYS LEU HIS GLY LYS SEQRES 13 A 446 GLU ILE ARG SER GLN LEU ASN GLU LYS VAL ALA GLN LEU SEQRES 14 A 446 TYR ALA ASP LEU ASP GLY GLY PHE SER HIS ALA ALA TRP SEQRES 15 A 446 LEU LEU PRO GLY TRP LEU PRO LEU PRO SER PHE ARG ARG SEQRES 16 A 446 ARG ASP ARG ALA HIS ARG GLU ILE LYS ASP ILE PHE TYR SEQRES 17 A 446 LYS ALA ILE GLN LYS ARG ARG GLN SER GLN GLU LYS ILE SEQRES 18 A 446 ASP ASP ILE LEU GLN THR LEU LEU ASP ALA THR TYR LYS SEQRES 19 A 446 ASP GLY ARG PRO LEU THR ASP ASP GLU VAL ALA GLY MET SEQRES 20 A 446 LEU ILE GLY LEU LEU LEU ALA GLY GLN HIS THR SER SER SEQRES 21 A 446 THR THR SER ALA TRP MET GLY PHE PHE LEU ALA ARG ASP SEQRES 22 A 446 LYS THR LEU GLN LYS LYS CYS TYR LEU GLU GLN LYS THR SEQRES 23 A 446 VAL CYS GLY GLU ASN LEU PRO PRO LEU THR TYR ASP GLN SEQRES 24 A 446 LEU LYS ASP LEU ASN LEU LEU ASP ARG CYS ILE LYS GLU SEQRES 25 A 446 THR LEU ARG LEU ARG PRO PRO ILE MET ILE MET MET ARG SEQRES 26 A 446 MET ALA ARG THR PRO GLN THR VAL ALA GLY TYR THR ILE SEQRES 27 A 446 PRO PRO GLY HIS GLN VAL CYS VAL SER PRO THR VAL ASN SEQRES 28 A 446 GLN ARG LEU LYS ASP SER TRP VAL GLU ARG LEU ASP PHE SEQRES 29 A 446 ASN PRO ASP ARG TYR LEU GLN ASP ASN PRO ALA SER GLY SEQRES 30 A 446 GLU LYS PHE ALA TYR VAL PRO PHE GLY ALA GLY ARG HIS SEQRES 31 A 446 ARG CYS ILE GLY GLU ASN PHE ALA TYR VAL GLN ILE LYS SEQRES 32 A 446 THR ILE TRP SER THR MET LEU ARG LEU TYR GLU PHE ASP SEQRES 33 A 446 LEU ILE ASP GLY TYR PHE PRO THR VAL ASN TYR THR THR SEQRES 34 A 446 MET ILE HIS THR PRO GLU ASN PRO VAL ILE ARG TYR LYS SEQRES 35 A 446 ARG ARG SER LYS SEQRES 1 B 446 GLY LYS LEU PRO PRO TYR ILE PHE SER PRO ILE PRO PHE SEQRES 2 B 446 LEU GLY HIS ALA ILE ALA PHE GLY LYS SER PRO ILE GLU SEQRES 3 B 446 PHE LEU GLU ASN ALA TYR GLU LYS TYR GLY PRO VAL PHE SEQRES 4 B 446 SER PHE THR MET VAL GLY LYS THR PHE THR TYR LEU LEU SEQRES 5 B 446 GLY SER ASP ALA ALA ALA LEU LEU PHE ASN SER LYS ASN SEQRES 6 B 446 GLU ASP LEU ASN ALA GLU ASP VAL TYR SER ARG LEU THR SEQRES 7 B 446 THR PRO VAL PHE GLY LYS GLY VAL ALA TYR ASP VAL PRO SEQRES 8 B 446 ASN PRO VAL PHE LEU GLU GLN LYS LYS MET LEU LYS SER SEQRES 9 B 446 GLY LEU ASN ILE ALA HIS PHE LYS GLN HIS VAL SER ILE SEQRES 10 B 446 ILE GLU LYS GLU THR LYS GLU TYR PHE GLU SER TRP GLY SEQRES 11 B 446 GLU SER GLY GLU LYS ASN VAL PHE GLU ALA LEU SER GLU SEQRES 12 B 446 LEU ILE ILE LEU THR ALA SER HIS CYS LEU HIS GLY LYS SEQRES 13 B 446 GLU ILE ARG SER GLN LEU ASN GLU LYS VAL ALA GLN LEU SEQRES 14 B 446 TYR ALA ASP LEU ASP GLY GLY PHE SER HIS ALA ALA TRP SEQRES 15 B 446 LEU LEU PRO GLY TRP LEU PRO LEU PRO SER PHE ARG ARG SEQRES 16 B 446 ARG ASP ARG ALA HIS ARG GLU ILE LYS ASP ILE PHE TYR SEQRES 17 B 446 LYS ALA ILE GLN LYS ARG ARG GLN SER GLN GLU LYS ILE SEQRES 18 B 446 ASP ASP ILE LEU GLN THR LEU LEU ASP ALA THR TYR LYS SEQRES 19 B 446 ASP GLY ARG PRO LEU THR ASP ASP GLU VAL ALA GLY MET SEQRES 20 B 446 LEU ILE GLY LEU LEU LEU ALA GLY GLN HIS THR SER SER SEQRES 21 B 446 THR THR SER ALA TRP MET GLY PHE PHE LEU ALA ARG ASP SEQRES 22 B 446 LYS THR LEU GLN LYS LYS CYS TYR LEU GLU GLN LYS THR SEQRES 23 B 446 VAL CYS GLY GLU ASN LEU PRO PRO LEU THR TYR ASP GLN SEQRES 24 B 446 LEU LYS ASP LEU ASN LEU LEU ASP ARG CYS ILE LYS GLU SEQRES 25 B 446 THR LEU ARG LEU ARG PRO PRO ILE MET ILE MET MET ARG SEQRES 26 B 446 MET ALA ARG THR PRO GLN THR VAL ALA GLY TYR THR ILE SEQRES 27 B 446 PRO PRO GLY HIS GLN VAL CYS VAL SER PRO THR VAL ASN SEQRES 28 B 446 GLN ARG LEU LYS ASP SER TRP VAL GLU ARG LEU ASP PHE SEQRES 29 B 446 ASN PRO ASP ARG TYR LEU GLN ASP ASN PRO ALA SER GLY SEQRES 30 B 446 GLU LYS PHE ALA TYR VAL PRO PHE GLY ALA GLY ARG HIS SEQRES 31 B 446 ARG CYS ILE GLY GLU ASN PHE ALA TYR VAL GLN ILE LYS SEQRES 32 B 446 THR ILE TRP SER THR MET LEU ARG LEU TYR GLU PHE ASP SEQRES 33 B 446 LEU ILE ASP GLY TYR PHE PRO THR VAL ASN TYR THR THR SEQRES 34 B 446 MET ILE HIS THR PRO GLU ASN PRO VAL ILE ARG TYR LYS SEQRES 35 B 446 ARG ARG SER LYS HET HEM A 601 43 HET PJM A 602 49 HET DXC A 603 28 HET DXC A 604 28 HET DXC A 605 28 HET DXC A 606 28 HET DXC A 607 28 HET DXC A 608 28 HET DXC A 609 28 HET DXC A 610 28 HET PJM A 611 49 HET HEM B 601 43 HET PJM B 602 49 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM PJM N-[(1R)-1-(3-CHLORO-4'-FLUORO[1,1'-BIPHENYL]-4-YL)-2- HETNAM 2 PJM (1H-IMIDAZOL-1-YL)ETHYL]-4-{5-[3-FLUORO-5-(5- HETNAM 3 PJM FLUOROPYRIMIDIN-4-YL)PHENYL]-1,3,4-OXADIAZOL-2- HETNAM 4 PJM YL}BENZAMIDE HETNAM DXC (3ALPHA,5BETA,12ALPHA)-3,12-DIHYDROXYCHOLAN-24-OIC ACID HETSYN HEM HEME HETSYN DXC DEOXYCHOLIC ACID FORMUL 3 HEM 2(C34 H32 FE N4 O4) FORMUL 4 PJM 3(C36 H23 CL F3 N7 O2) FORMUL 5 DXC 8(C24 H40 O4) FORMUL 16 HOH *29(H2 O) HELIX 1 AA1 HIS A 73 SER A 80 1 8 HELIX 2 AA2 SER A 80 GLY A 93 1 14 HELIX 3 AA3 GLY A 110 SER A 120 1 11 HELIX 4 AA4 ALA A 127 GLY A 140 1 14 HELIX 5 AA5 VAL A 143 VAL A 147 5 5 HELIX 6 AA6 PRO A 148 LEU A 163 1 16 HELIX 7 AA7 ASN A 164 PHE A 183 1 20 HELIX 8 AA8 VAL A 194 HIS A 211 1 18 HELIX 9 AA9 GLY A 212 SER A 217 1 6 HELIX 10 AB1 ASN A 220 GLY A 232 1 13 HELIX 11 AB2 SER A 235 LEU A 241 1 7 HELIX 12 AB3 LEU A 247 SER A 274 1 28 HELIX 13 AB4 ASP A 280 ALA A 288 1 9 HELIX 14 AB5 THR A 297 ASP A 330 1 34 HELIX 15 AB6 ASP A 330 GLY A 346 1 17 HELIX 16 AB7 THR A 353 LYS A 358 1 6 HELIX 17 AB8 LEU A 360 ARG A 374 1 15 HELIX 18 AB9 SER A 404 GLN A 409 1 6 HELIX 19 AC1 ASN A 422 LEU A 427 5 6 HELIX 20 AC2 ASN A 430 GLU A 435 1 6 HELIX 21 AC3 ALA A 444 ARG A 448 5 5 HELIX 22 AC4 GLY A 451 LEU A 469 1 19 HELIX 23 AC5 HIS B 73 SER B 80 1 8 HELIX 24 AC6 SER B 80 GLY B 93 1 14 HELIX 25 AC7 GLY B 110 SER B 120 1 11 HELIX 26 AC8 ALA B 127 GLY B 140 1 14 HELIX 27 AC9 VAL B 143 VAL B 147 5 5 HELIX 28 AD1 PRO B 148 LEU B 163 1 16 HELIX 29 AD2 ASN B 164 PHE B 183 1 20 HELIX 30 AD3 GLU B 184 TRP B 186 5 3 HELIX 31 AD4 VAL B 194 GLY B 212 1 19 HELIX 32 AD5 GLY B 212 SER B 217 1 6 HELIX 33 AD6 ASN B 220 GLY B 232 1 13 HELIX 34 AD7 SER B 235 LEU B 241 1 7 HELIX 35 AD8 LEU B 247 SER B 274 1 28 HELIX 36 AD9 ASP B 280 ALA B 288 1 9 HELIX 37 AE1 THR B 297 ASP B 330 1 34 HELIX 38 AE2 ASP B 330 GLY B 346 1 17 HELIX 39 AE3 THR B 353 LYS B 358 1 6 HELIX 40 AE4 LEU B 360 ARG B 374 1 15 HELIX 41 AE5 SER B 404 GLN B 409 1 6 HELIX 42 AE6 ASN B 422 GLN B 428 5 7 HELIX 43 AE7 ASN B 430 GLU B 435 1 6 HELIX 44 AE8 ALA B 444 ARG B 448 5 5 HELIX 45 AE9 GLY B 451 LEU B 469 1 19 SHEET 1 AA1 5 VAL A 95 MET A 100 0 SHEET 2 AA1 5 LYS A 103 LEU A 108 -1 O PHE A 105 N PHE A 98 SHEET 3 AA1 5 GLN A 400 VAL A 403 1 O CYS A 402 N THR A 106 SHEET 4 AA1 5 MET A 380 ALA A 384 -1 N ARG A 382 O VAL A 401 SHEET 5 AA1 5 LEU A 125 ASN A 126 -1 N ASN A 126 O MET A 383 SHEET 1 AA2 3 SER A 189 ASN A 193 0 SHEET 2 AA2 3 VAL A 495 ARG A 500 -1 O ILE A 496 N LYS A 192 SHEET 3 AA2 3 TYR A 470 ASP A 473 -1 N ASP A 473 O ARG A 497 SHEET 1 AA3 2 GLN A 388 VAL A 390 0 SHEET 2 AA3 2 TYR A 393 ILE A 395 -1 O ILE A 395 N GLN A 388 SHEET 1 AA4 2 VAL A 482 ASN A 483 0 SHEET 2 AA4 2 THR A 490 PRO A 491 -1 O THR A 490 N ASN A 483 SHEET 1 AA5 5 VAL B 95 MET B 100 0 SHEET 2 AA5 5 LYS B 103 LEU B 108 -1 O PHE B 105 N PHE B 98 SHEET 3 AA5 5 GLN B 400 VAL B 403 1 O GLN B 400 N THR B 104 SHEET 4 AA5 5 MET B 380 ALA B 384 -1 N ARG B 382 O VAL B 401 SHEET 5 AA5 5 LEU B 125 ASN B 126 -1 N ASN B 126 O MET B 383 SHEET 1 AA6 3 SER B 189 ASN B 193 0 SHEET 2 AA6 3 VAL B 495 ARG B 500 -1 O ILE B 496 N LYS B 192 SHEET 3 AA6 3 TYR B 470 ASP B 473 -1 N ASP B 473 O ARG B 497 SHEET 1 AA7 2 GLN B 388 VAL B 390 0 SHEET 2 AA7 2 TYR B 393 ILE B 395 -1 O ILE B 395 N GLN B 388 SHEET 1 AA8 2 VAL B 482 ASN B 483 0 SHEET 2 AA8 2 THR B 490 PRO B 491 -1 O THR B 490 N ASN B 483 LINK SG CYS A 449 FE HEM A 601 1555 1555 2.22 LINK FE HEM A 601 NAZ PJM A 602 1555 1555 2.10 LINK SG CYS B 449 FE HEM B 601 1555 1555 2.37 LINK FE HEM B 601 NAZ PJM B 602 1555 1555 2.08 CRYST1 117.664 117.664 157.842 90.00 90.00 90.00 I 4 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008499 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008499 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006335 0.00000